GW Pharma

FDA just approved the first prescription drug derived from marijuana: 4 outstanding questions
Medical Marketing and Media
Tue, 06/26/18 - 10:17 pm
FDA
GW Pharma
Epidiolex
epilepsy
CBD
drug pricing
DEA
FDA approves country’s first medicine made from marijuana
Stat
Mon, 06/25/18 - 12:51 pm
GW Pharma
Epidiolex
epilepsy
FDA
Dravet syndrome
Lennox-Gastaut Syndrome
marijuana
3 Biotechs With Huge FDA Decisions in June
Motley Fool
Thu, 05/31/18 - 10:00 pm
biotech
Array Biopharma
encorafenib
binimetinib
GW Pharma
Epidiolex
Incyte
olumiant
This Cannabis-Based Drug Is On the Verge of Making History
Motley Fool
Sun, 05/20/18 - 08:40 pm
GW Pharma
Epidiolex
CBD
Dravet syndrome
Lennox-Gastaut Syndrome
FDA
A look at The First Company Likely to Market an FDA Approved Cannabinoid in the US
CP Wire
Mon, 04/30/18 - 06:47 pm
GW Pharma
Epidiolex
FDA
cannabinoids
FDA Panel Votes To Approve Marijuana-Based Drug For Epilepsy
Forbes
Thu, 04/19/18 - 11:52 pm
FDA
GW Pharma
Epidiolex
epilepsy
advisory panels
GW Pharma riding high as cannabinoid Epidiolex nears first U.S. approval
Fierce Biotech
Wed, 04/18/18 - 09:33 am
GW Pharma
Epidiolex
FDA
epilepsy
3 Biotechs That Could Get Big Boosts in April
Motley Fool
Wed, 03/28/18 - 10:02 am
biotech
GW Pharma
Epidiolex
Incyte
olumiant
baricitinib
Neurocrine Biosciences
Elagolix
3 Blockbuster Drug Launches to Watch In 2018
Motley Fool
Mon, 03/26/18 - 10:45 am
drug launches
Gilead Sciences
HIV
Biktarvy
Alnylam
Sanofi
Patisiran
Epidiolex
GW Pharma
12 blockbusters: The surging list of $1B-plus drugs rolling out on the market this year might surprise you
Endpoints
Thu, 03/22/18 - 09:21 am
drug launches
Hemlibra
Roche
Biktarvy
Gilead Sciences
Ozempic
Novo Nordisk
Erleada
JNJ
Shingrix
GSK
Patisiran
Alnylam
Sanofi
Epidiolex
GW Pharma
Aimovig
Amgen
Novartis
lanadelumab
Shire
Elagolix
AbbVie
Steglatro
Pfizer
Merck
Sublocade
Indivior
GW Pharma shares dented after cannabinoid drug fails a PhIIa study on focal seizures
Endpoints
Wed, 02/21/18 - 11:00 pm
GW Pharma
clinical trials
cannabinoids
Epidiolex
seizures
The top 10 prospective blockbuster drug launches slated for 2018 — Evaluate
Endpoints
Sun, 12/17/17 - 11:47 am
drug launches
Bictegravir/F/TAF
Gilead Sciences
semaglutide
Novo Nordisk
epacadostat
Incyte
Rova-T
AbbVie
ozanimod
Celgene
apalutamide
JNJ
Elagolix
AVXS-101
AveXis
lanadelumab
Shire
Epidiolex
GW Pharma
After a decade of work, Otsuka and GW part ways on Sativex
BioPharma Dive
Wed, 12/13/17 - 06:33 pm
Otsuka
GW Pharma
Sativex
cannabindoids
Could Marijuana Stock GW Pharmaceuticals Soar More Than 50%?
Motley Fool
Tue, 10/31/17 - 09:32 am
GW Pharma
marijuana
A Tiny Biotech Just Dealt a Big Blow to Marijuana's Use in Epilepsy
Motley Fool
Mon, 10/2/17 - 11:09 am
biotech
marijuana
epilepsy
ZX008
Zogenix
Epidiolex
GW Pharma
seizures
The 1 Word in GW Pharmaceuticals' Q3 Update That Disappointed Investors
Motley Fool
Tue, 08/8/17 - 10:07 am
GW Pharma
earnings
investors
Zogenix: Could This Be The Greatest Threat to GW Pharmaceuticals?
Motley Fool
Tue, 06/6/17 - 09:35 am
Zogenix
GW Pharma
Sativex
Epidiolex
LGS
Dravet syndrome
GW Pharmaceuticals’ Cannabis Drug Show Promise in Late-Stage Clinical Trial of Epilepsy
Xtalks
Tue, 05/30/17 - 10:08 am
GW Pharma
cannabis
clinical trials
Epidiolex
epilepsy
Dravet syndrome
3 Reasons GW Pharmaceuticals Stock Could Rise
Motley Fool
Sun, 01/22/17 - 01:34 pm
GW Pharma
Epidiolex
Top 6 Biopharma Gainers of the Past Week
24/7 Wall St
Tue, 10/4/16 - 10:20 am
Catabasis
Sarepta Therapeutics
Anavex
Biogen
Array Biopharma
GW Pharma

Pages